Bafna Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr Krishna Yeachuri as an Independent Director of the company w.e.f. close of business hours of March 31, 2025.
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bafna Pharmaceuticals Limited has informed the stock exchanges that Mr. Krishna Yeachuri (DIN: 00066898) has resigned as an Independent Director of the company, effective from the close of business hours on March 31, 2025. He cited pre-occupation and other personal commitments as the reasons for his departure. As a result, he has also stepped down as the Chairman of the company's Nomination & Remuneration Committee. Mr. Yeachuri confirmed there are no other material reasons behind his resignation beyond what was stated. He also continues to serve as a Non-Executive, Non-Independent Director on the board of Megasoft Limited.
This is a routine independent director resignation for personal reasons with no governance red flags raised. Shareholders should note that the Nomination & Remuneration Committee will need a new chairman, and the company will need to fill the vacant independent director position to maintain statutory board composition requirements.